-The Times of India NEW DELHI: With 9,787 regular and 4,447 contract drivers on its payroll, Delhi Transport Corporation has one of the largest resource pools in the city. Unfortunately, these drivers are calling attention to the corporation for all the wrong reasons. Since 2011, the number of accidents involving DTC buses has steadily gone up with a corresponding increase in fatalities. Complaints of rash driving have been pouring in, prompting frequent...

-The Indian Express In the wake of the collapse of the Saradha chit fund company, the Information & Broadcasting Ministry has asked all television channels - general entertainment as well as news and current affairs - to furnish details of their shareholding pattern and equity structure. This includes the Saradha Group. According to sources, the ministry's letter, sent on Friday, asks channels to inform whether there had been any changes in their...

-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...

-The Hindu The Saradha group's spectacular failure has inflicted severe pain not only on its gullible depositors and agents but in a real sense on India's financial regulators and the State government as well. There is a law and order problem in West Bengal. Very soon, public attention will shift to regulation or the lack of it. The crisis, it appears, will not be confined to one state. In the worst...

-Economic and Political Weekly The Supreme Court judgment on the Novartis-Glivec case is remarkable because it has gone beyond the specific technical and legal issues surrounding patents and has put the matter in a much larger political and economic perspective. The deeper implication of the judgment is that it is not only justified to deny patents when incremental innovation is trivial as in the Glivec case. The judgment has linked the...